Press Releases

CD Formulation Extends Holiday Greetings for 2023 with an Exclusive Discount

Alfa Chemistry Launches Varieties of Biological Reagents for Use in Nucleic Acid Purification Systems

BOC Sciences and Spaya Join Forces to Expand Chemical Offerings

BOC Sciences, a leading chemical supplier, has partnered with Spaya, an AI-powered chemical synthesis platform, to enhance the portfolio of commercially available materials by listing an unprecedented 140,000+ chemical products.

Amerigo Scientific Highlights Cell-Free Expression Supplies with pEU Vector Set

Dr. Vince Clinical Research Launches New Solution for Organ Impairment Studies

Huateng Pharma Introduces Versatile Ingredients for Cosmetics and Commodities

Huateng Pharma introduces Tetrahydrocurcumin, a dual-action antioxidant and skin-whitening agent, alongside Pro-xylane and (S)-Pro-xylane, potent anti-ageing agents, and Piroctone Olamine, an effective anti-dandruff solution, emphasizing a commitment to quality and versatility from lab to commercial scale.

Andelyn Biosciences Selected by Ultragenyx for Late-Stage Process Performance Qualification (PPQ) Manufacturing of Novel Gene Therapy for Sanfilippo Syndrome

Columbus, OH, December 18, 2023 - Andelyn Biosciences, Inc., a pioneering and patient-focused cell and gene therapy Contract Development and Manufacturing Organization (CDMO), announced that it has been selected by Ultragenyx (NASDAQ: RARE) to perform late-stage Process Performance Qualification (PPQ) manufacturing of the company’s UX111 gene therapy for the potential treatment of Sanfilippo Syndrome (MPS IIIA).

Creative Biostructure Unveils Comprehensive Panel of Exosomes Isolated from Human Disease-State Body Fluids

Matexcel Provides Expansive Array of Bio-ink Products for Different Applications

Lifeasible Simplifies Gene Editing with CRISPR Mutation Library Construction Services

Creative Enzymes Unleashes Revolutionary Trypsin-Chymotrypsin, Elevating Protease Research to New Heights

Creative Enzymes Releases Microorganism-Derived Bilirubin Oxidase

Creative Proteomics Launches Innovative Ubiquitinated Proteomics Service for Advanced Research

Creative Proteomics Launches Label-free Quantification Service for Advanced Protein Analysis

Empower Your Research with Creative Proteomics' Innovative Pull-Down Assay Service

Stability Analysis Plays a Crucial Role in Pharmaceutical Formulation, Highlighted by CD Formulation

Abzena partners with FDA on publication demonstrating the benefits of the MAPPs assay for immunogenicity

Abzena, a leading CDMO for biologics, collaborates with the FDA on a publication endorsing the MHC Associated Peptide Proteomics (MAPPs) assay for assessing immunogenicity in drug development. The article underscores MAPPs' precision in identifying potential immunogenicity risks in early preclinical stages, reducing the likelihood of anti-drug antibodies (ADAs) and optimizing biologics. Abzena integrates MAPPs into its immunogenicity services, aiming to de-risk drug development. The Chief Scientific Officer, Dr. Campbell Bunce, emphasizes the assay's value in informing drug regions that may induce ADAs. The collaboration aims to expedite safer, more effective therapies for patients

Recipharm harmonizes its global quality operations with Veeva Vault Quality

Hope you are well and are having a great week so far! I just wanted to pass on the latest news from Recipharm, who has chosen Veeva Systems to streamline global quality operations. The move aims to enhance oversight, resource efficiency, validation speed, and inspection readiness. The full release is below. Thank you Charlotte

Alfa Chemistry Leads the Way to Unleash Power of Computational Solutions in Solid State Chemistry for Pharmaceutical Research

PrecisionLife Project Awarded Innovate UK Grant to Improve Diagnosis and Treatment of ME/CFS and Long Covid

Leading computational biology company PrecisionLife®, which is driving precision medicine in complex chronic diseases, the ME/CFS charity Action for M.E., and the MRC Human Genetics Unit at the Institute of Genetics and Cancer, University of Edinburgh have been awarded a £622,000 grant by Innovate UK's Advancing Precision Medicine programme to improve diagnosis and treatment for the millions of people affected by ME/CFS and long Covid.